브루클라인 캐피털 어퀴지션 코퍼레이션 II(BCACU) is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 10.2M | Perf Week | - |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | - |
| Book/sh | 0 | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | - | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | - | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | - | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.06 | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.06 | Sales Q/Q | - | SMA20 | - | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | - | Rel Volume | - | Prev Close | - |
| Employees | 3 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | - | Avg Volume(3M) | - | Price | - |
| IPO | - | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
Brookline Capital Acquisition Corp II (BCACU) Investment Analysis
What kind of company is Brookline Capital Acquisition Corp II?
A SPAC focused on acquiring innovative companies in the healthcare and defense technology sectors. It has raised $100 million and aims to create new business opportunities through strategic mergers with high-growth technology companies.
Learn more about Brookline Capital Acquisition Corp II →Key Events
BCACU의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.
- 실적 발표는 보통 분기마다 있습니다
- 배당주는 연 1~4회 배당락일이 있습니다
Is it profitable?
What's the outlook?
Analyst estimates and price targets have not been collected.
Did earnings meet expectations?
No analyzable past earnings releases have been collected yet.
Has the stock risen over the long term?
Is it attractive at this price?
Key metrics such as PER and PBR are unavailable, so valuation is omitted.
Who owns it?
How much does it pay in dividends?
It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.
Compare Industry Peers
| Stock | Market Cap | PER | PBR | ROE | Dividend Yield | Change |
|---|---|---|---|---|---|---|
| - | - | - | - | - | - | |
BRK-B | $966.4B | 14.8 ▼ | 1.5 ▼ | 10.49% ▲ | - | +0.5% |
BRK-A | $963.1B | 14.8 ▼ | 1.5 ▼ | 10.49% ▲ | - | +0.1% |
JPM | $954.4B | 15.3 ▼ | 2.7 ▼ | 17.71% ▲ | 1.8% ▼ | +0.8% |
V | $683.1B | 31.9 ▼ | 19.4 ▼ | 59.8% ▲ | 0.75% ▼ | +1.9% |
MA | $487.5B | 31.9 ▼ | 72.8 ▼ | 232.56% ▲ | 0.63% ▼ | +2.2% |
| Sector Avg | - | 13.6 | 1.3 | 9.39% | 2.62% | - |
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.